Bone Marrow Aspirate Concentrates Market Size

Bone Marrow Aspirate Concentrates Market Size

Bone Marrow Aspirate Concentrates Market size was valued at around USD 172.8 million in 2023 and is anticipated to register a CAGR of over 5.4% between 2024 and 2032. Bone marrow aspirate concentrate (BMAC) is a form of regenerative therapy that involves harvesting a patient's own bone marrow, processing it to concentrate the stem cells and growth factors, and then injecting it into areas of the body where tissue repair or regeneration is needed. The increasing applications of BMAC is a significant driver for the market.<

To get key market trends

  Download Free Sample

For instance, according to the published report in America Journal Roentgenology, in 2023, various studies have demonstrated significant improvements in pain, function, and outcomes for patients with knee osteoarthritis (OA) and osteochondral lesions. BMAC injections have shown to be effective in improving functional scores, reducing pain, and enhancing knee function in patients. Therefore, BMAC offers a minimally invasive, autologous (using the patient's own cells) treatment option with potentially quicker recovery times.
 

Furthermore, market growth is accredited to several factors, including the rising prevalence of orthopedic disorders, growing adoption of bone & joint health supplements, which is estimated to reach 26.4 billion by 2032, growing geriatric population, surging awareness and acceptance of regenerative medicine, and favorable regulatory environment.